Heart Rhythm
Volume 6, Issue 6 , Pages 749-751 , June 2009

The leadless ultrasonic pacemaker: A sound idea?

  • David G. Benditt, BScEE, MD, FACC, FRCPC, FHRS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. David G. Benditt, University of Minnesota Medical School, Cardiac Arrhythmia Center, Mail Code 508, 420 Delaware Street SE, Minneapolis, Minnesota, 55455
    • ,
  • MaryAnn Goldstein, MD
    • ,
  • Andres Belalcazar, BSEE, PhD

References 

  1. Stokes KM, Donders AP. Leadless multisite implantable stimulus and diagnostic system (US Patent 5,814,089). 1998;September 29
  2. Hastings RN, Lafontaine DM, Pikus MJ, et al. Cardiac stimulation using leadless electrode assemblies. US Patent Application 2009/0018599, January15 2009;
  3. Jacobson PM. Leadless cardiac pacemaker triggered by conductive communication. US Patent Application 2007/0088398, April 19 2007;
  4. Goto H, Sugiura T, Harada Y, et al. Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source. Med Biol Eng Comput. 1999;37:377–380
  5. Lee KL, Tse H-F, Echt DS, et al. Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on acoustic window. Heart Rhythm. 2009;6:742–748
  6. Echt DS, Cowan MW, Riley RE, et al. Feasibility and safety of a novel technology for pacing without leads. Heart Rhythm. 2006;3:1202–1206
  7. Sweeney MO. In a footnote, at least. Heart Rhythm. 2006;3:1207–1209
  8. Snoeck J, Berkhof M, Claeys M, et al. External vibration interference of activity based rate responsive pacemakers. Pacing Clin Electrophysiol. 1992;15:1841–1845
  9. Fetter JG, Benditt DG, Stanton MS. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site. J Am Coll Cardiol. 1996;28:423–427
  10. Fetter JG, Ivans V, Benditt DG, et al. Digital cellular telephone interaction with implanted cardioverter defibrillators. J Am Coll Cardiol. 1998;31:623–628
  11. Pinski S. Electromagnetic interference and implantable devices. In:  Ellenbogen KA,  Kay GN,  Lau C-P, et al. editor. Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Third edition. Philadelphia: WB Saunders/Elsevier; 2007;p. 1149–1176

 Dr. Benditt is a consultant for Medtronic, Inc., St. Jude Medical, Inc., Transoma, Inc., and Nanostim, Inc., and holds equity in Boston Scientific, Inc., Medtronic, and St. Jude Medical. Dr. Goldstein is a consultant for Medtronic and holds equity in Boston Scientific, Medtronic, and St. Jude Medical.

PII: S1547-5271(09)00402-0

doi: 10.1016/j.hrthm.2009.04.006

Heart Rhythm
Volume 6, Issue 6 , Pages 749-751 , June 2009

Article Tools